18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and SurvivalGiulia Polverari, Désirèe Deandreis, Roberto Passera et al.|Cancers|2020Cited by 97
Event-free survival after 68 Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapyFrancesco Ceci, Désirèe Deandreis, Valeria Chiofalo et al.|European Journal of Nuclear Medicine and Molecular Imaging|2022Cited by 26
Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced MelanomaVirginia Liberini, Désirèe Deandreis, Adriana Lesca et al.|Journal of Clinical Medicine|2021Cited by 5
Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced MelanomaVirginia Liberini, Désirèe Deandreis, Adriana Lesca et al.|Preprints.org|2021Cited by 4
Event-Free Survival after 68Ga-PSMA-11 PET/CT in recurrent Hormone-Sensitive Prostate Cancer (HSPC) patients eligible for Salvage Therapy.Francesco Ceci, Désirèe Deandreis, Valeria Chiofalo et al.|Research Square|2021Cited by 2